IHL 0.00% 4.1¢ incannex healthcare limited

News: IHL Incannex Healthcare Receives IRB Approval For Reposa Phase 2/3 Clinical Trial Protocol, page-7

  1. 502 Posts.
    lightbulb Created with Sketch. 77
    Another very important box ticked. More to come, IRB's in Europe next please!!biggrin.png
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.